Steroidogenesis and early response gene expression in MA-10 Leydig tumor cells following heterologous receptor down-regulation and cellular desensitization

door Chen, Tsuey-Ming, Czerwiec, Frank S., Puett, David
Gepubliceerd in Biochem Biophys Rep (2016)

Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial

door Shoaf, Susan E., Chapman, Arlene B., Torres, Vicente E., Ouyang, John, Czerwiec, Frank S.
Gepubliceerd in J Clin Pharmacol (2017)

Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4

door Devuyst, Olivier, Chapman, Arlene B., Shoaf, Susan E., Czerwiec, Frank S., Blais, Jaime D.
Gepubliceerd in Kidney Int Rep (2017)

Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion

door Verbalis, Joseph G, Adler, Suzanne, Schrier, Robert W, Berl, Tomas, Zhao, Qiong, Czerwiec, Frank S
Gepubliceerd in 2011

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

door Gralla, Richard J., Ahmad, Fatima, Blais, Jaime D., Chiodo, Joseph, Zhou, Wen, Glaser, Linda A., Czerwiec, Frank S.
Gepubliceerd in Cancer Med (2017)

Prevalence of autosomal dominant polycystic kidney disease in the European Union

door Willey, Cynthia J., Blais, Jaime D., Hall, Anthony K., Krasa, Holly B., Makin, Andrew J., Czerwiec, Frank S.
Gepubliceerd in Nephrol Dial Transplant (2017)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease

door Edwards, Marie E, Blais, Jaime D, Czerwiec, Frank S, Erickson, Bradley J, Torres, Vicente E, Kline, Timothy L
Gepubliceerd in Clin Kidney J (2018)

The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations

door Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Gepubliceerd in Kidney Int Rep (2020)

A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD

door Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Gepubliceerd in Kidney Int Rep (2020)

Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia

door Berl, Tomas, Quittnat-Pelletier, Friederike, Verbalis, Joseph G., Schrier, Robert W., Bichet, Daniel G., Ouyang, John, Czerwiec, Frank S.
Gepubliceerd in 2010

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

door Torres, Vicente E., Devuyst, Olivier, Chapman, Arlene B., Gansevoort, Ron T., Perrone, Ronald D., Ouyang, John, Blais, Jaime D., Czerwiec, Frank S., Sergeyeva, Olga
Gepubliceerd in Am J Nephrol (2017)

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney dise...

door Torres, Vicente E, Chapman, Arlene B, Devuyst, Olivier, Gansevoort, Ron T, Perrone, Ronald D, Dandurand, Ann, Ouyang, John, Czerwiec, Frank S, Blais, Jaime D
Gepubliceerd in Nephrol Dial Transplant (2018)

Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial

door Devuyst, Olivier, Chapman, Arlene B., Gansevoort, Ron T., Higashihara, Eiji, Perrone, Ronald D., Torres, Vicente E., Blais, Jaime D., Zhou, Wen, Ouyang, John, Czerwiec, Frank S.
Gepubliceerd in J Am Soc Nephrol (2017)

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

door Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Grantham, Jared J., Higashihara, Eiji, Perrone, Ronald D., Krasa, Holly B., Ouyang, John, Czerwiec, Frank S.
Gepubliceerd in 2012

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial

door Torres, Vicente E., Higashihara, Eiji, Devuyst, Olivier, Chapman, Arlene B., Gansevoort, Ronald T., Grantham, Jared J., Perrone, Ronald D., Ouyang, John, Blais, Jaime D., Czerwiec, Frank S.
Gepubliceerd in Clin J Am Soc Nephrol (2016)

Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys

door Kline, Timothy L., Korfiatis, Panagiotis, Edwards, Marie E., Blais, Jaime D., Czerwiec, Frank S., Harris, Peter C., King, Bernard F., Torres, Vicente E., Erickson, Bradley J.
Gepubliceerd in J Digit Imaging (2017)

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience

door Higashihara, Eiji, Torres, Vicente E., Chapman, Arlene B., Grantham, Jared J., Bae, Kyongtae, Watnick, Terry J., Horie, Shigeo, Nutahara, Kikuo, Ouyang, John, Krasa, Holly B., Czerwiec, Frank S.
Gepubliceerd in 2011

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

door Perrone, Ronald D., Mouksassi, Mohamad-Samer, Romero, Klaus, Czerwiec, Frank S., Chapman, Arlene B., Gitomer, Berenice Y., Torres, Vicente E., Miskulin, Dana C., Broadbent, Steve, Marier, Jean F.
Gepubliceerd in Kidney Int Rep (2017)

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease

door Perrone, Ronald D., Mouksassi, Mohamad-Samer, Romero, Klaus, Czerwiec, Frank S., Chapman, Arlene B., Gitomer, Berenice Y., Torres, Vicente E., Miskulin, Dana C., Broadbent, Steve, Marier, Jean F.
Gepubliceerd in Kidney Int Rep (2017)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

door Casteleijn, Niek F., Blais, Jaime D., Chapman, Arlene B., Czerwiec, Frank S., Devuyst, Olivier, Higashihara, Eiji, Leliveld, Anna M., Ouyang, John, Perrone, Ronald D., Torres, Vicente E., Gansevoort, Ron T.
Gepubliceerd in Am J Kidney Dis (2016)